19
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      International Journal of Nanomedicine (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on the application of nanotechnology in diagnostics, therapeutics, and drug delivery systems throughout the biomedical field. Sign up for email alerts here.

      105,621 Monthly downloads/views I 7.033 Impact Factor I 10.9 CiteScore I 1.22 Source Normalized Impact per Paper (SNIP) I 1.032 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Pumpkin Oil–Based Nanostructured Lipid Carrier System for Antiulcer Effect in NSAID-Induced Gastric Ulcer Model in Rats

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Peptic ulcer disease, a painful lesion of the gastric mucosa, is considered one of the most common gastrointestinal disorders. This study aims to investigate the formulation of pumpkin seed oil (PSO)-based nanostructured lipid carriers (NLCs) to utilize PSO as the liquid lipid component of NLCs and to achieve oil dispersion in the nano-range in the stomach.

          Methods

          Box–Behnken design was utilized to deduce the optimum formula with minimum particle size. The optimized PSO-NLCs formula was investigated for gastric ulcer protective effects in Wistar rats by evaluating ulcer index and determination of gastric mucosa oxidative stress parameters.

          Results

          PSO was successfully incorporated as the liquid lipid (LL) component of NLCs. The prepared optimum PSO-NLCs formula showed a size of 64.3 nm. Pretreatment of animals using the optimized PSO-NLCs formula showed significantly (p< 0.001) lower ulcer index compared to indomethacin alone group and significantly (p<0.05) less mucosal lesions compared to the raw oil.

          Conclusion

          These results indicated great potential for future application of optimized PSO-NLCs formula for antiulcer effect in non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcer.

          Most cited references45

          • Record: found
          • Abstract: found
          • Article: not found

          Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer.

          Nanoscale drug delivery systems using liposomes and nanoparticles are emerging technologies for the rational delivery of chemotherapeutic drugs in the treatment of cancer. Their use offers improved pharmacokinetic properties, controlled and sustained release of drugs and, more importantly, lower systemic toxicity. The commercial availability of liposomal Doxil and albumin-nanoparticle-based Abraxane has focused attention on this innovative and exciting field. Recent advances in liposome technology offer better treatment of multidrug-resistant cancers and lower cardiotoxicity. Nanoparticles offer increased precision in chemotherapeutic targeting of prostate cancer and new avenues for the treatment of breast cancer. Here we review current knowledge on the two technologies and their potential applications to cancer treatment.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Solid lipid nanoparticles as a drug delivery system for peptides and proteins.

            Solid lipid particulate systems such as solid lipid nanoparticles (SLN), lipid microparticles (LM) and lipospheres have been sought as alternative carriers for therapeutic peptides, proteins and antigens. The research work developed in the area confirms that under optimised conditions they can be produced to incorporate hydrophobic or hydrophilic proteins and seem to fulfil the requirements for an optimum particulate carrier system. Proteins and antigens intended for therapeutic purposes may be incorporated or adsorbed onto SLN, and further administered by parenteral routes or by alternative routes such as oral, nasal and pulmonary. Formulation in SLN confers improved protein stability, avoids proteolytic degradation, as well as sustained release of the incorporated molecules. Important peptides such as cyclosporine A, insulin, calcitonin and somatostatin have been incorporated into solid lipid particles and are currently under investigation. Several local or systemic therapeutic applications may be foreseen, such as immunisation with protein antigens, infectious disease treatment, chronic diseases and cancer therapy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine.

              A new direct colorimetric procedure for uric acid assay in serum or urine is described, utilizing a 3,5-dichloro-2-hydroxybenzene sulfonic acid/4-aminophenazone chromogenic system in the presence of horseradish peroxidase and uricase from Aspergillus flavus. This chromogen system has a high absorptivity, affording useful results with sample/reagent volume ratios as low as 0.025. The procedure is applicable to serum, plasma, or diluted urine. A single working reagent is used; the reaction is complete in less than 15 min at room temperature. The red dye formed is measured at 520 nm; a blank sample measurement is not needed. The standard curve for the method is linear for uric acid concentrations up to 1500 mumol/L. Average analytical recovery of uric acid in human sera and urine exceeded 99%; within-run and between-run precision studies showed CV's of less than or equal to 1.2 and less than or equal to 2.2%, respectively. The new procedure correlated well with the uricase/catalase and uricase/ultraviolet methods. The method is suitable for automation.
                Bookmark

                Author and article information

                Journal
                Int J Nanomedicine
                Int J Nanomedicine
                IJN
                intjnano
                International Journal of Nanomedicine
                Dove
                1176-9114
                1178-2013
                15 April 2020
                2020
                : 15
                : 2529-2539
                Affiliations
                [1 ]Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University , Jeddah 21589, Saudi Arabia
                [2 ]Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Minia University , Minia 61519, Egypt
                [3 ]Department of Pharmacology, School of Pharmacy, Ibn Sina National College , Jeddah 22413, Saudi Arabia
                [4 ]Department of Pharmacology and Toxicology, Faculty of Pharmacy, Minia University , Minia 61519, Egypt
                [5 ]Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University , Jeddah, Saudi Arabia
                [6 ]Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University , Jeddah 21589, Saudi Arabia
                [7 ]Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University , Jeddah 21589, Saudi Arabia
                [8 ]King Fahd Medical Research Center, King Abdulaziz University , Jeddah 21589, Saudi Arabia
                Author notes
                Correspondence: Osama AA Ahmed Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University , Jeddah21589, Saudi ArabiaTel +966 599120686 Email oaahmed@kau.edu.sa
                Author information
                http://orcid.org/0000-0002-3204-381X
                http://orcid.org/0000-0001-9875-6399
                http://orcid.org/0000-0001-8655-6656
                http://orcid.org/0000-0002-3826-1519
                Article
                247252
                10.2147/IJN.S247252
                7167276
                32346290
                f14d39ca-25c0-44b9-b9f0-a2a3cc090a01
                © 2020 Ahmed et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 25 January 2020
                : 29 March 2020
                Page count
                Figures: 7, Tables: 3, References: 53, Pages: 11
                Categories
                Original Research

                Molecular medicine
                natural products,gastric ulcer,pumpkin seed oil,nano-lipid carriers,optimization,box–behnken experimental design

                Comments

                Comment on this article